Oppenheimer & Co »

Catalyst Pharmaceutical Partners shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 81k 19.88
2024-03-31 $806k 51k 15.94

More positions owned by Oppenheimer & Co

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)

View all positions for Oppenheimer & Co

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Royce & Associates
Goldman Sachs Group
Northern Trust
Robeco Investment Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners